Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis

Abstract

WBMRI provides a comprehensive phenotype of neurofibromatosis patients, identifies distinct anatomic subgroups, and provides the basis for investigating molecular biomarkers that correlate with unique disease manifestations.